CRA is a proud sponsor of the first-ever GAR Live: Life Sciences, evolving from the much-loved Technology Disputes event to reflect the growing complexity and importance of life sciences in international arbitration. This brand new conference will bring together leading arbitrators, counsel, experts and in-house professionals working at the intersection of science, innovation and dispute resolution. Expect dynamic discussions on unique challenges, regulatory frameworks and emerging disputes.
Greg Bell is a panelist during the session titled “Patents, products, and problems: managing IP and device disputes.”
Intellectual property and medical devices sit at the heart of life sciences disputes, where cutting-edge technology meets complex contractual frameworks. This panel will explore how arbitration is being used to resolve IP and device-related issues in high-value transactions. From licensing and patent rights to regulatory hurdles and cross-border enforcement, discover the trends shaping arbitration in this critical sector.
For more information on this event, click here.
